Home Research Our research Research we fund Markers of disease progression

Markers of disease progression

There is currently no diagnostic test for MND and no specific ‘biomarker’ to monitor the disease. These projects aim to find a marker of disease progression to speed up diagnosis, prognosis and disease monitoring of MND. Read the latest news on biomarkers in MND on our MND Research blog.

An asterisk (‘*’) next to a title marks the research projects that directly involve animals.

Biomedical projects

Micro RNAs as a biomarker of disease progression (839-791)*
Development of confocal endomicroscopy for MND research (838-791)*
Looking for non-coding RNA biomarkers in the blood and CSF (836-791)
A Multicentre Biomarker Resource Strategy in ALS: AMBRoSIA (972-797)
How do genetic variations affect biomarkers? (NECTAR) (974-797)
TDP-43 dependent non-canonical RNAs in ALS patient samples (853-791)


Developing the Biomarkers in Oxford Project (944-795)
Using surface EMG recordings to measure muscle fasciculations (947-795)
Development and validation of a new combined approach for tracking the progress of MND (966-799)

Last updated: 1 October 2017

This web site uses cookies to help improve your online experience. Please click accept if you are happy with this. Accept Find Out More
We’ve recently updated our privacy policy, find out how we use your data.